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1. Introduction
  Marine sponges provide classic examples of microbial-
macro faunal partnerships that have been a productive 
source for the discovery of bioactive compounds[1].Natural 
products are organic molecules derived from plants, 
animals, or microorganisms, and represent the starting 
point for most of the anti-infective and anti-cancer drugs 
on the market today. Until recently, the majority of natural 
products have been isolated from terrestrial sources. During 
the last two decades, however, the rate of discovery of novel 
compounds has declined significantly, as exemplified 
by the fact that extracts from soil-derived actinomycetes 
have yielded unacceptably high numbers of previously 
described metabolites[2]. Bioactive compounds  are 
frequently associated with marine invertebrates, including 
sponges, bryozoans, mollusks,and tunicates[3]. More 
recently, marine microorganisms have been recognized 
as a productive source of novel secondary metabolites. To 
date, the majority of natural products of marine bacterial 
origin have arisen from a small number of taxonomic groups 
that include Streptomyces, Alteromonas, Pseudomonas, 
Vibrio, Agrobacterium, and the cyanobacteria[4,5]. Over the 
past decade, a consensus has developed among marine 
natural products chemists and chemical ecologists, who 
believe that most novel natural products found in extracts 
of marine invertebrates are synthesized, either in part or in 
their entirely, by the symbiotic microbes that are intimately 
associated with these marine metazoans. According to 
chemical ecologists, secondary metabolites are produced 
as part of a chemical arsenal designed to deter grazers by 
imparting toxicity or low palatability to the metazoan host. 
These marine invertebrate-microbial assemblages also 
produce toxic compounds to prevent colonization by other 
non-beneficial microbial species. Interestingly, some of the 
small molecules isolated from marine metazoans display a 
striking resemblance to prokaryotic-borne metabolites. It 
has thus been suggested that the source of many of these 
bioactive is in fact the symbiotic microorganisms[6].These 
reviews suggest the enormous potential of sponge derived 
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fungi in therapeutic aspects. Hence, this work focuses 
on exploring the marine niche to isolate and characterize 
at least one such novel bioactive compounds that can be 
formulated for clinical purpose. 
 
2. Materials and methods 
2.1. Biological material  
  In the present study sponge sample was collected at a 
depth of 5-10 m by self-contained underwater breathing 
apparatus (SCUBA) diving from Kovalam Coast which is 
situated on the west coast of Kerala about 14 km to the south 
of Thiruvananthapuram at 8°23’ N latitude and 76°57’ 
E longitude in India. Samples of sponges were collected 
in sterile polythene bags and transported to the laboratory 
within minimum possible time to avoid the external 
microbial contamination and excessive proliferation. All the 
epiphytic faunas were removed.
2.2. Isolation of fungi and preparation of extract 
  The sponge sample was washed with sterile water (distilled 
water÷sea water=1÷1) and ground in a mortar and pestle 
under aseptic conditions. One mL of the above was mixed 
with 9 mL of sterile water (distilled water÷seawater=1÷1) 
to get dilution10-1 aseptically. The serial dilution was 
repeated till 10-6. From each dilution plating was done in 
Sabourauds agar by spread plate technique. The plates were 
then incubated at 27 ℃ for 5 days. After 5 days, the plates 
were examined and the pure culture was isolated on pure 
agar plate.
  The fungal mycelia were homogenized using sea water. 
Then the biomass was subjected to an extraction of 
biologically active components which were carried out 
with different solvents in the order of increase polarity: 
hexane, ethyl acetate and methanol by soaking at ambient 
temperature. The residues (crude extracts) thus obtained 
were finally dried under rotary vacuum evaporator and 
screened against two human pathogen bacteria using the 
agar disk diffusion method.
2.3. Antibacterial assay
  Antibacterial activity was carried out against human 
pathogenic gram negative bacterium [Escherichia coli 
(E. coli), ATCC 25922] and gram positive bacterium 
[Staphylococcus aureus (S. aureus), ATCC 29213] by agar well 
diffusion method. Muller Hinton agar plates were prepared 
and wells were made by using gel puncture. Test culture 
was swabbed aseptically and inoculated on the surface of 
the nutrient agar so as to make a lawn. This was allowed for 
5 mins for the agar surface to dry before making the wells. 
One mL of fungal filtrate was mixed with 1  mL of the solvent 
from which various (15 毺L, 25毺L, 50毺L/well) concentrations 
and loaded in the well using micropipette and one well was 
loaded with the respective solvent as control. Plates were 
incubated for 16 to 18 hrs at 37 ℃. The zone of inhibition 
was observed around the well. This indicates whether the 
test organism is resistant (no zone of inhibition) or sensitive 
(clear zone of inhibition).
2.4. Purification and characterization of bioactive metabolites
 One mL of fungal extract was mixed with 1 gm of silica 
gel and loaded on a silica gel column packed with hexane 
and eluted with hexane and chloroform (9÷1 to 1÷9 and 
100% chloroform) followed by ethyl acetate and methanol 
(9÷1 to 1÷9 and 100% methanol). The absorbance of eluted 
fractions was measured in the UV-Visible spectrum. The gas 
chromatography-mass spectrometry (GC-MS)  equipped with 
Agilent 5975 inert XL MSD was used for analysis of bioactive 
secondary metabolites. Infra-Red spectroscopy was used 
to investigate and predict any physiochemical interactions 
between different components in a formulation using 
Fouvier-transform infrared (FT-IR). The spectra obtained 
through those samples were compared and interpreted for 
the shifting of functional peaks.  
2.5. Molecular characterization and Identification of elite 
fungi by internal transcribed spacer (ITS) sequencing 
  The fungi were grown in culture in potato dextrose 
broth at room temperature in the dark for 48 to 72 hours. 
The genomic DNA was isolated and the ITS region of 
5.8sRNA was amplified using primer ITS1: Forward 
5’  TCCGTAGGTGAACCTGCGG 3’ and Reverse ITS5 5’ 
TCCTCCGCTTATTGATATGC 3’ [7] and sequenced using 
automated sequencer.
3. Results 
3.1. Isolation of fungi from sponge
  The sponge identification was confirmed as Callyspongia 
spp based on spicules morphology. Six different associated 
fungi like Aspergilus niger, Aspergilus flavus (A. flavus), 
Hypocrea lixii ,  Trichoderma hypericum ,  Eurotium 
amstelodami and an unidentified fungi were isolated from 
the sponge. 
3.2. Antibacterial activity of the isolated fungi 
  Ethyl extract of A. flavus showed promising result by 
exhibiting maximum activity against two significant human 
pathogens S. aureus and E. coli. The zone of inhibition using 
A. flavus biomass was measured as 31 mm for E. coli and 18 
mm for S. aureus. The fungal filtrate was more effective by 
producing 42 mm zone of inhibition for E .coli and 27 mm for 
S. aureus.
3.3. Characterization of bioactive metabolites
  The crude fungal filtrate was separated using column 
chromatography and fraction 9 showed maximum 
absorbance. Hence, fraction 9 was subjected to further 
analysis to identify the bioactive compound. The gas 
chromatography result of fungal filtrate reveals that the 
active compound of A. flavus are Desmethylnomifensine 
(27.72%), 2-Butenoic acid (12.29%), 2-Benzoic acid (8.62%) 
and 7H-Furo furo xanthen-7-one (6.86%). 
3.4. FT-IR spectrum 
  The FT-IR spectrum of Aspergillus niger extract in ethyl 
acetate showed bands at 3 350cm-1, 2 945 cm-1, 2 832 cm-1, 
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2 522 cm-1, 2 227 cm-1 and 2 044 cm-1 correspond to the 
stretching vibrations of primary and secondary amines, 
respectively, while  the band seen at 1 660 cm-1 corresponds 
to amide (C=O) (Figure 1). The two bands observed at 1 447 
cm-1 and 1 115 cm-1 can be assigned to the C-N stretching. 
Vibrations of aromatic and aliphatic amines, respectively. 
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Figure  1. FT-IR spectrum. 
3.5. Molecular characterization and identification of elite 
fungi 
  Blast search sequence similarity was found against the 
existing non redundant nucleotide sequence database 
thus, identifying the fungi as A. flavus. The percentage of 
similarity between the fungi and database suggested it as 
novel strain. Thus, the novel strain was named as  A. flavus 
strain MV5 and made publically available in GenBank with 
an assigned accession number GU815344 (http://www.ncbi.
nlm.nih.gov/nuccore/GU815344.1)
4. Discussion
  Ethyl extract of A. flavus showed maximum activity. The 
activity present in the fungal extracts of least diameter of 
zone inhibition was considered as positive. It was already 
reported that some marine fungi produced active metabolites 
secreted from mycelia8 and culture filterate[9,10]. In this 
study also both culture filtrate and biomass were used and 
exhibited reasonable antibacterial activity. 
  The activity present from fungal culture filtrates has been 
conducted and proven by many studies[9,11, 12]. However, 
the low activity from the fungal mycelia does not indicate 
that this fungus does not have any antibacterial activity. 
The production of active metabolites can be boosted in 
many ways such as by using other microbes to compete for 
space and nutrients and the use of different media supplied 
with different nutrient sources with different physiological 
parameters such as pH, temperature, salinity and light[13, 14]. 
On the other hand, extraction of fungal mycelia using the 
different solvent is one way to determine the actual activity 
from fungal mycelia. Solvent system serves different 
functions in the extractions of different compounds in 
fungus. Crude extracts and purified fractions of Aspergillus 
spp showe of antimicrobial activity. Similarly, several 
metabolites of the marine isolate, Aspergillus niger show 
antibacterial and antifungal potential which supports the 
present study.
  The isolate exhibits a marked antagonistic activity against 
potential bacterial pathogens thus illuminating the advanced 
researches in this decade to focus on clinical pharmacology 
to identify novel therapeutic targets. Since, the terrestrial 
environment seems to be exploited thoroughly, marine 
sources act as replenished source of bioactive compounds 
that have a diverse spectrum of activity. These results depict 
a promising scenario to focus on such marine microbe 
derived compounds which can be easily scaled up for large 
biomass production and stable formulation as a drug. 
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